Senior insider sale
Chief Scientific Officer at VOYAGER THERAPEUTICS, INC. — senior position signals high conviction
$202.1K
21K shares
What this filing means
CARTER TODD ALFRED plans to sell 21K shares of VOYAGER THERAPEUTICS, INC. valued at approximately $202.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/15/2023ACC: 0001959173-23-003960
Officer· Chief Scientific Officer
Since Feb 2026
21K
Shares to sell
$202.1K
Approx. market value
10.50K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months4
Option Granted - 01/13/2022
Cash
9/15/2023
5KRestricted Stock Vesting
Compensation
3/19/2022
3.57KRestricted Stock Vesting
Compensation
2/16/2022
1.32KRestricted Stock Vesting
Compensation
2/10/2022
602.00Total acquired10.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/15/2023 | Option Granted - 01/13/2022 Cash | 5K | — |
3/19/2022 | Restricted Stock Vesting Compensation | 3.57K | — |
2/16/2022 | Restricted Stock Vesting Compensation | 1.32K | — |
2/10/2022 | Restricted Stock Vesting Compensation | 602.00 | — |
| Total | 10.50K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
5.50K
Market value
$59.4K
7/6/2023
—Completed
Units to sell
5K
Market value
$57.0K
6/30/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
10.50K
Market value
$85.7K
9/15/2023
Total
Units
21K
Value
$202.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/6/2023 | 5.50K | $59.4K | — | Completed |
6/30/2023 | 5K | $57.0K | — | Completed |
| Planned — Approximate Date | ||||
9/15/2023 | 10.50K | $85.7K | NASDAQ | Planned |
| Total | 21K | $202.1K | ||